Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statin after multidrug therapy for multibacillary leprosy
RBR-96xpfnPhase 3Recruiting
- Sponsor
- Oswaldo Cruz Institute
- Start
- Jul 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label trial of ulinastatin in leprosy (HD) (2 arms), sponsored by Oswaldo Cruz Institute. Started Jul 2019; status: recruiting.
02
Drugs
ulinastatin
03
Conditions
leprosy (HD)
Beyond the preview
Go deeper on RBR-96xpfn.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-96xpfn.